Title
Category
Credits
Event date
Cost
  • Disease management
  • Health equity
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 ASWB - Social Workers
$0.00
Living with a rare disease impacts individuals and their family/caregivers, both physically and mentally. This podcast will share insights and perspectives directly from Erica Barnes and provide strategies that the interprofessional health care team can utilize to better support those impacted by rare diseases such as leukodystrophies.
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will highlight new updates in our understanding of how diabesity develops and describe the negative physiologic effects of this disease on multiple body systems, notably the cardiovascular and renal systems. Optimal treatments for diabesity will be identified, along with an overview of the health burden of diabesity related to long-term complications and reduced function, quality of life and life expectancy. 
  • Disease management
  • Older adults
  • Wellness
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
$0.00
This activity will highlight the prevalence of UI; provide effective communication and shared decision-making techniques; and discuss how to assess, treat and provide follow-up care for UI including available resources to support care and management.
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will explore the value of PRO measures in the health system and discuss methods of optimally integrating these measures. It will discuss strategies that the health care team and health system can use to interpret and apply PRO data to add value to current care delivery practices.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will focus on the evaluation and management of oculomotor symptoms associated with acquired brain injuries (ABI) due to concussion, stroke and other causes. It will discuss the battery of tests that can establish the presence of oculomotor dysfunction and will cover available treatment options, including glasses, prism glasses, therapeutic eye drops and vision therapy. The importance of a team management approach through collaboration and referrals will be stressed. After this activity, eye doctors should be comfortable evaluating patients with a history of concussion or ABI.
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will provide a current update to participants’ comprehensive knowledge and understanding of various contact lens options for patients with common diagnoses requiring medically necessary contact lenses. This session will delve into the tool chest of contact lens solutions, including standard rigid gas permeable (RGP) lens designs, reverse geometry RGPs, hybrids and scleral lenses. Participants will explore the anatomy of contact lenses, specific designs and applications for conditions such as keratoconus and irregular corneas. The activity will also cover the advantages and considerations associated with each lens type, patient experiences and advancements in scleral lens designs.
  • Behavioral health
  • Disease management
  • Palliative care and hospice
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 Attendance - General Attendance
$0.00
Activity descriptionConversations that provide patients who have serious and life-threatening illnesses with the opportunity to make informed choices reflecting their goals, values and care preferences are a critical part of their care. These discussions can help ensure that seriously ill patients receive care that is consistent with their wishes and provide guidance to enhance family well-being and improve the patient’s quality of life.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join this session to explore updates in genetic therapy for two prevalent hemaglobinopathies: sickle cell disease and beta thalassemia.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
The potential consequences of medical misinformation on public health, such as the spread of vaccine hesitancy, will be discussed, and participants will come away empowered with additional strategies and tools to more effectively address medical misinformation and promote accurate health information to patients and the wider community.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will focus on enhancing our understanding of the current opioid crisis and will explore new angles and address current concerns, including the use of over-the-counter intranasal naloxone, the evolving landscape of opioids with a focus on fentanyl, the intersection between suicide and opioid overdoses, the significance of the new 988 helpline in the crisis, and the viability of home-based detox startups. Strategies to effectively address the ongoing challenges of the opioid crisis will be discussed.

Pages